AIRLINK 196.51 Increased By ▲ 4.67 (2.43%)
BOP 10.07 Increased By ▲ 0.20 (2.03%)
CNERGY 7.81 Increased By ▲ 0.14 (1.83%)
FCCL 38.46 Increased By ▲ 0.60 (1.58%)
FFL 15.72 Decreased By ▼ -0.04 (-0.25%)
FLYNG 24.54 Decreased By ▼ -0.77 (-3.04%)
HUBC 130.10 Decreased By ▼ -0.07 (-0.05%)
HUMNL 13.70 Increased By ▲ 0.11 (0.81%)
KEL 4.60 Decreased By ▼ -0.07 (-1.5%)
KOSM 6.20 Decreased By ▼ -0.01 (-0.16%)
MLCF 45.05 Increased By ▲ 0.76 (1.72%)
OGDC 206.65 Decreased By ▼ -0.22 (-0.11%)
PACE 6.60 Increased By ▲ 0.04 (0.61%)
PAEL 39.70 Decreased By ▼ -0.85 (-2.1%)
PIAHCLA 17.15 Decreased By ▼ -0.44 (-2.5%)
PIBTL 7.98 Decreased By ▼ -0.09 (-1.12%)
POWER 9.12 Decreased By ▼ -0.12 (-1.3%)
PPL 179.40 Increased By ▲ 0.84 (0.47%)
PRL 38.51 Decreased By ▼ -0.57 (-1.46%)
PTC 24.20 Increased By ▲ 0.06 (0.25%)
SEARL 109.15 Increased By ▲ 1.30 (1.21%)
SILK 1.01 Increased By ▲ 0.04 (4.12%)
SSGC 37.78 Decreased By ▼ -1.33 (-3.4%)
SYM 18.80 Decreased By ▼ -0.32 (-1.67%)
TELE 8.51 Decreased By ▼ -0.09 (-1.05%)
TPLP 12.12 Decreased By ▼ -0.25 (-2.02%)
TRG 64.69 Decreased By ▼ -1.32 (-2%)
WAVESAPP 12.01 Decreased By ▼ -0.77 (-6.03%)
WTL 1.64 Decreased By ▼ -0.06 (-3.53%)
YOUW 3.87 Decreased By ▼ -0.08 (-2.03%)
BR100 12,000 Increased By 69.2 (0.58%)
BR30 35,548 Decreased By -112 (-0.31%)
KSE100 114,256 Increased By 1049.3 (0.93%)
KSE30 35,870 Increased By 304.3 (0.86%)

A vaccine for run-of-the-mill flu also provides some protection against swine flu, especially the severest forms of the disease, Mexican scientists report on October 07. The authors stress, however, that their study is limited in scale and that they see no evidence for dropping programmes to vaccinate against the pandemic H1N1 virus.
Investigators led by Jose Luis Valdespino-Gomez, an epidemiologist at the national laboratory Birmex, compared 60 patients who had fallen sick with swine flu with other people, matched for age and background, who were being treated for other diseases.
The patients were asked whether they had received the 2008-2009 seasonal vaccine, a cocktail of three antigens designed to prime the immune system to overlapping flu strains that circulated in the northern hemisphere last year. The doctors looked at a subset of patients who had each been hospitalised - 45 in the flu group and 60 in the control group. Vaccination against seasonal flu provided effectiveness of 80 percent against catching swine flu, they found.
"This study presents clinical data suggesting that this vaccine may provide some protection," says the article, published online by the British Medical Journal.
"Moreoever, that none of the vaccinated cases of influenza A/H1N1 died indicates that seasonal vaccination might protect against the most severe forms of the disease."
The authors speculate that the H1N1 is closely related to a previous virus to which people had been exposed. Giving these people the seasonal vaccine helped prime their antibodies, the first line in the immune defences, to fight off swine flu virus.
They emphasise that wider probes are needed in order to confirm their findings. The swine flu scare has cost billions in terms of economic damage and bills for formulating a specific vaccine against the virus.
As of September 27, there had been more than 340,000 laboratory confirmed cases of H1N1 and over 4,100 deaths, according to a World Health Organisation toll issued on last week. The WHO says that swine flu is about as lethal as an ordinary seasonal virus but cautions that the pathogen could mutate into a form that would make it more virulent.

Copyright Agence France-Presse, 2009

Comments

Comments are closed.